Continuous blood glucose monitoring by artificial pancreas in patients with intracranial hypertension

Continuous blood glucose monitoring by artificial pancreas in patients with intracranial hypertension - Blood Glucose Monitoring by Artificial Pancreas -Intracranial Hypertension (GMAP-IH)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012307

Enrollment

Registered

2013-11-18

Start date

2013-11-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients having brain diseases (brain trauma, stroke, and brain tumor, etc.) suffers intracranial hypertension which requires emergency decompressive surgery.

Interventions

During decompressive surgery blood glucose is continuously monitored by artificial pancreas. Blood is sampled at a 2mL/hr from peripheral vein.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Unconscious (JCS 10-200) Tolerable for general anesthesia Men and women of 20 years of age or older Unnecessary of insulin treatment Informed consent written by legally acceptable representative

Exclusion criteria

Exclusion criteria: Necessary of insulin treatment Requirement of glucose administration before and during surgery Pregnant or lactating women and women of child bearing potential Patients judged by investigators ineligible for participation as study subjects for any other reason.

Design outcomes

Primary

Measure	Time frame
Correlation between glucose change and decompressive manuplation during surgery	—

Countries

Japan

Contacts

Public ContactMotomasa Furuse

Osaka Medical College Neurosurgery

neu054@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026